Niviron. Connecting technology and business

Слайд 2

We work for

State universities, institutes and centers

Private scientific organizations

Private independent laboratories and

We work for State universities, institutes and centers Private scientific organizations Private
research groups

CRO

Слайд 3

Main services

TLO/TTO outsourced

Finding funding for research activities

Promotion of university services

search for the

Main services TLO/TTO outsourced Finding funding for research activities Promotion of university
legal successor of technology

legal support of the transaction

marketing activities to promote technology (at own expense)

preparation of technology for transfer (packaging, legal issues. Format)

state funds and corporations (preparation of documents for filing an application)

charitable trust funds

private sponsors

private and corporate investors

Search for a sponsor among:

contract research

clinical trials

joint development

Слайд 4

Additional services

Market research and analytics

Protection of intellectual property *

competitor analysis
market volume analysis
determining

Additional services Market research and analytics Protection of intellectual property * competitor
the potential future value and value of the technology
determination of the budget for bringing the technology to the market

literary property
licensing and strategic alliances

patent

privacy and data security
trademark

* we use third-party contactors - professionals in their field

Слайд 5

We have direct access:*

1.500 managers of biotech companies (oncology) (your target audience)

We have direct access:* 1.500 managers of biotech companies (oncology) (your target
including Bayer AG, etc.
1.000 investors in the biotech industry
We have indirect access:**
60.000 CEOs of other tech companies
15.000 biotech investors and sponsors
We can send up to 200 requests per day to the target audience

Our opportunities

* already established contact
** there are all contacts in the database, but we did not have a precedent to refer to them earlier
!!! We do not declare that we have partnerships with all our contractors, but we can directly contact the key persons of the company

Слайд 6

Avangard

description description description description

Our partners

Avangard

description description description description

Avangard

description description description description

Avangard description description description description Our partners Avangard description description description description

Слайд 7

About our company
The company is based on 27 Drydock Avenue, 8th floor,

About our company The company is based on 27 Drydock Avenue, 8th
Boston, Massachusetts 02210877.HACK.DNA / 877.422.5362
The mission of our company is to extend the qualities and life of a person by promoting new technologies to the market.

Слайд 8

Our team

I
Founder

Vitaly
Founder

Bessarion
Founder

Lena
Founder

Liza
Founder

Olya
Founder

Our team I Founder Vitaly Founder Bessarion Founder Lena Founder Liza Founder Olya Founder

Слайд 9

As part of our services, we focus on:

Oncology (main focus)

Autoimmune diseases

Diseases of

As part of our services, we focus on: Oncology (main focus) Autoimmune
the central nervous system

Connect with us if you need our help. Let's speed up the process of bringing technologies to practical use together

Endocrine diseases

Infectious diseases

Tissue Engineering / Transplantology

Cardiovascular diseases

Aging

Слайд 10

Business model

Technology licensing

Series B Financing

Series A Financing

intellectual property protection

registration of the company's

Business model Technology licensing Series B Financing Series A Financing intellectual property
rights to the technology

selection of necessary team members

search for an investor of the series A financing
phase I clinical trials

technology development preclinical trials
submission of clinical trials application
search for an investor of the series B financing

Sale of technology/ company
(! + royalties from sales)

Series C Financing
phase II clinicak trials

Sale of technology/ company
(! + royalties from sales)

Profit

!!! This is an optimistic plan for the company's development. We understand there is a high probability that the technology will not be able to reach the market for many reasons.

We are ready for such a development of events. We are ready to start the process again and again until we achieve the main goal that we have set for our company - to increase the duration and quality of human life by promoting technologies aimed at solving the problems facing modern oncology.

Слайд 11

The process of collecting a contact base

screen

patent base

biotech base crunch base

clinical trials

Market

The process of collecting a contact base screen patent base biotech base
analysis
Creation of a list of companies promoting similar technology, the search is carried out in the patent database, the catalog of clinical trials and the database of companies (crunch base, biotech gate)

Слайд 12

We go to the profiles of each company and find information about

We go to the profiles of each company and find information about
the investors who financed this company

crunchable another base

Creating a list of investors

Finding contacts of key employees and collecting them into a final file

Sending a database of contacts to the client

Имя файла: Niviron.-Connecting-technology-and-business.pptx
Количество просмотров: 37
Количество скачиваний: 0